Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Atlanta-Sandy Springs-Marietta, GA MSA — October 2026
Atlanta regulatory pay climbs as national rates retreat.
Metro Regulatory Affairs Specialist pay rose to $114,750 against a national decline to $103,780, while Lab Technician pay fell to $43,680 amid Georgia's $22.90 average manufacturing wage.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Metro unemployment rate: 3.5% — Up from 3.4% a year ago, still below 4.1% national
- Regulatory Affairs pay, metro vs national: $114,750 vs $103,780 — Metro up moderately, national down moderately
- Open pharma manufacturing jobs, Georgia: 367 — Against 44% R&D job growth 2019-2022
- Georgia pharma manufacturing hourly pay: $22.90 — Below competitive biotech hub wage levels
Key takeaways
Regulatory pay in Atlanta is diverging from the national trend.
Metro Regulatory Affairs Specialist pay rose to $114,750 while national pay moved down moderately to $103,780 — a local premium of roughly 10%. Atlanta employers appear to be bidding up compliance talent ahead of EU regulatory deadlines even as the national market cools, a signal worth testing against current job architecture.
CRA scarcity is showing up directly in advertised pay.
Metro CRA pay rose sharply to $71,908 and national pay to $90,065, consistent with national research showing experienced CRAs are the real bottleneck. Build-vs-outsource decisions on CRO partnerships should account for this gap closing over 2026.
Lab Technician pay is falling as manufacturing wages stay low statewide.
Metro Lab Technician pay dropped significantly to $43,680, tracking Georgia's statewide pharma manufacturing hourly average of $22.90 — among the lowest in competitive biotech geographies. Retention risk concentrates here as Meissner's 1,700-job Athens-Clarke expansion and Boston Scientific's Johns Creek R&D hub compete for the same technical labor pool.
Clinical Data Manager pay looks out of step with national demand.
Metro pay fell significantly to $97,384 against a stable national median of $123,653, a nearly $26,000 gap. Current conditions suggest this role may be undervalued locally relative to the data management capacity biotech and CDMO growth will require.
Median advertised pay by role — Atlanta-Sandy Springs-Marietta, GA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $78,475 | $95,859 | $122,593 | Stable | $130,339 |
| Clinical Research Associate | $60,039 | $71,908 | $93,990 | Significant increase | $90,065 |
| Lab Technician | $38,291 | $43,680 | $50,350 | Significant decline | $47,840 |
| Regulatory Affairs Specialist | $72,008 | $114,750 | $117,369 | Moderate increase | $103,780 |
| Clinical Data Manager | $97,351 | $97,384 | $120,895 | Significant decline | $123,653 |
| Biostatistician | $89,454 | $127,805 | $143,770 | Significant increase | $131,958 |
| Validation Engineer | $98,382 | $112,023 | $133,125 | Significant increase | $106,478 |
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Atlanta's labor force and payroll employment hit all-time highs in September even as unemployment edged up to 3.5%, with the gain concentrated in healthcare and government while professional, scientific and technical services shed 7,600 jobs over the year. That sectoral split — growth in regulated, credential-heavy employment alongside contraction in the broader scientific services category — is consistent with a life sciences labor market where specialized roles stay tight while general professional hiring softens.
What it means
Regulatory Affairs Specialist pay in metro Atlanta has climbed to a $114,750 median, now running ahead of the national figure even as national regulatory pay has pulled back moderately — a reversal that suggests Atlanta employers are competing hard for compliance-fluent talent tied to the EUDAMED and EU AI Act rollouts referenced in national research notes. Clinical Research Associate advertised pay rose sharply both locally and nationally, reinforcing that CRA capacity remains the binding constraint on clinical trial headcount planning and a factor in CRO reliance. Organizations should evaluate whether current regulatory and CRA compensation structures reflect this market's upward pay movement before defaulting to outsourcing as a cost-containment strategy.
Looking ahead
Early indicator: Watch whether Meissner's Athens-Clarke facility and Boston Scientific's Johns Creek hub begin advertising quality, automation and digital production roles in volume — both expansions signal demand for workers Georgia's current manufacturing wage base may not retain.
Emerging pressure point: Only 367 pharma manufacturing jobs are open statewide against a workforce that grew 44% in R&D roles from 2019-2022, a mismatch that could push more quality and manufacturing work toward CDMOs over the next two quarters.
Worth watching: Professional, scientific and technical services employment fell 7,600 year-over-year across metro Atlanta even as healthcare added 15,000 jobs — track whether life sciences R&D and lab functions are absorbing any of that contraction or sitting outside it.
Potential inflection point: National quit rate sits at 1.9% with 64% of biopharma organizations actively recruiting, meaning growth plans are colliding with candidates who are staying put. Expect counteroffer activity to intensify for regulatory and CRA talent specifically.
Sources
- Georgia Department of Labor — Atlanta labor force and employment hit all-time highs in September 2026
- North Atlanta Star — Professional, scientific and technical services shed 7,600 jobs year-over-year
- Industry biopharma hiring survey — Hardest-to-fill pharma roles include regulatory affairs and clinical operations
- Georgia Life Sciences Manufacturing Council — Georgia average pharma manufacturing hourly pay is $22.90
- Georgia economic development reporting — Meissner Corp $250M facility expected to create 1,700+ jobs in Athens-Clarke County
- Biopharma workforce survey — National quit rate at 1.9% with 64% of biopharma firms actively recruiting
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.